Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Nanovibronix, Inc. (NAOV : NSDQ)
 
 • Company Description   
NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York.

Number of Employees: 16

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.64 Daily Weekly Monthly
20 Day Moving Average: 231,810 shares
Shares Outstanding: 28.00 (millions)
Market Capitalization: $17.78 (millions)
Beta: 0.60
52 Week High: $4.19
52 Week Low: $0.48
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -17.81% -10.28%
12 Week -16.21% -9.45%
Year To Date -38.93% -27.67%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
525 EXECUTIVE BLVD
-
ELMSFORD,NY 10523
USA		 ph: 914-233-3004
fax: 914-376-6111		 naov@crescendo-ir.com http://www.nanovibronix.com
 
 • General Corporate Information   
Officers
Brian Murphy - Chief Executive Officer and Director
Christopher Fashek - Chairman of the Board of Directors
Stephen Brown - Chief Financial Officer
Martin Goldstein - Director
Harold Jacob - Director

Peer Information
Nanovibronix, Inc. (ABMD)
Nanovibronix, Inc. (DMDS)
Nanovibronix, Inc. (CPWY.)
Nanovibronix, Inc. (EQUR)
Nanovibronix, Inc. (ECIA)
Nanovibronix, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 63008J108
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 28.00
Most Recent Split Date: (:1)
Beta: 0.60
Market Capitalization: $17.78 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.81
Price/Cash Flow: -
Price / Sales: 10.49
EPS Growth
vs. Year Ago Period: 10.00%
vs. Previous Quarter: -125.00%
Sales Growth
vs. Year Ago Period: 761.11%
vs. Previous Quarter: 55.31%
ROE
03/31/22 - -
12/31/21 - -179.15
09/30/21 - -185.03
ROA
03/31/22 - -
12/31/21 - -125.00
09/30/21 - -108.85
Current Ratio
03/31/22 - -
12/31/21 - 4.38
09/30/21 - 35.43
Quick Ratio
03/31/22 - -
12/31/21 - 4.29
09/30/21 - 34.68
Operating Margin
03/31/22 - -
12/31/21 - -621.71
09/30/21 - -898.02
Net Margin
03/31/22 - -
12/31/21 - -842.60
09/30/21 - -1,268.71
Pre-Tax Margin
03/31/22 - -
12/31/21 - -840.71
09/30/21 - -1,257.92
Book Value
03/31/22 - -
12/31/21 - 0.23
09/30/21 - 0.36
Inventory Turnover
03/31/22 - -
12/31/21 - 4.91
09/30/21 - 2.60
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©